Zisook S, Downs N S
Department of Psychiatry, University of California, San Diego, La Jolla 92093-0603, USA.
J Clin Psychiatry. 1998;59 Suppl 4:80-91.
Major depression and dysthymia are common and often disabling disorders in late life. Several features of late-life depression, such as its frequent association with general medical conditions, polypharmacy, cognitive disturbances, and adverse life events, make accurate diagnosis a substantial clinical challenge. Yet, prompt diagnosis is an important component of implementing appropriate treatment strategies. An ideal treatment program integrates patient and family education, focused psychotherapy, and pharmacotherapy. Because of pharmacokinetic and pharmacodynamic changes associated with aging, lower doses of medication and more gradual dose increases than are required in younger adults are needed in the treatment of elderly depressed patients. In addition, medications should be selected that have minimal antihistaminic, anticholinergic, and antiadrenergic effects, minimal cardiovascular risk, and minimal drug-drug interactions. Since depression in late life tends to be at least as chronic and/or recurrent as depression earlier in life, treatment for acute depressive episodes should last at least 6-8 months, and long-term maintenance treatment should be considered in selected individuals.
重度抑郁症和心境恶劣障碍在老年期很常见,且往往会导致残疾。老年期抑郁症的几个特征,比如它常常与一般医疗状况、多种药物治疗、认知障碍以及不良生活事件相关联,这使得准确诊断成为一项重大的临床挑战。然而,及时诊断是实施恰当治疗策略的一个重要组成部分。一个理想的治疗方案应将患者及家属教育、有针对性的心理治疗和药物治疗结合起来。由于衰老会导致药代动力学和药效动力学发生变化,在治疗老年抑郁症患者时,所需药物剂量比年轻成年人更低,剂量增加也应更缓慢。此外,应选择抗组胺、抗胆碱能和抗肾上腺素能作用最小、心血管风险最低且药物相互作用最少的药物。鉴于老年期抑郁症往往至少和生命早期的抑郁症一样具有慢性和/或复发性,急性抑郁发作的治疗应持续至少6 - 8个月,对于部分患者应考虑进行长期维持治疗。